secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMV Pharmaceuticals, Inc. (PMVP)
CIK:        0001699382
Form:       8-K
Filed at:   2026-06-05T12:10:26+00:00
Accession:  0001193125-26-258466
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PMV Pharma annual meeting reelects Mack and Stelzer as Class III directors
--------------------------------------------------------------------------

- David H. Mack, Ph.D. elected with 15,693,907 for, 6,248,461 withheld; Laurie Stelzer with 11,261,111 for, 10,681,257 withheld.
- Non-binding say-on-pay resolution approved: 15,015,578 for, 6,468,718 against, 458,072 abstain.
- Ernst & Young ratified as independent auditor for FY2026: 28,379,108 for, 536,302 against, 2,370 abstain.
- Broker non-votes on director election and say-on-pay totaled 6,975,412 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699382/000119312526258466/0001193125-26-258466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699382/000119312526258466/d94814d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-258466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer